Issue Date | Title | Involved Person(s) |
17-Dec-2021 | Effect of the FDA black box suicidality warnings for antidepressants on suicide rates in the USA : signal or noise? | Plöderl, Martin; Hengartner, Michael Pascal |
8-Nov-2021 | Learning about the course of suicidal behavior but not about the effects of SSRIs | Plöderl, Martin; Hengartner, Michael Pascal |
2021 | Prophylactic effects or withdrawal reactions? : an analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA | Hengartner, Michael Pascal; Plöderl, Martin |
2021 | Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression | Hengartner, Michael Pascal; Plöderl, Martin |
2021 | Maintenance therapy with antidepressants : prophylactic effects or withdrawal reactions? | Plöderl, Martin; Hengartner, Michael P. |
2021 | Suicidality and other severe psychiatric events with duloxetine : re-analysis of safety data from a placebo-controlled trial for juvenile fibromyalgia | Hengartner, Michael Pascal; Plöderl, Martin |
2021 | Suicide risk with selective serotonin reuptake inhibitors and other new-generation serotonergic-noradrenergic antidepressants in adults : a meta-analysis of observational studies | Hengartner, Michael P.; Plöderl, Martin; Amendola, Simone; Kindler, Simone; Bschor, Tom, et al |
2021 | Latrogenic effects of the FDA black box warning on antidepressants – signal or noise? | Plöderl, Martin; Hengartner, Michael P. |
2021 | Suicide risk with selective serotonin reuptake inhibitors and other new-generation antidepressants in adults: a systematic review and meta-analysis of observational studies | Hengartner, Michael Pascal; Amendola, Simone; Kaminski, Jakob A.; Kindler, Simone; Bschor, Tom, et al |